This proposal is the current stage of an ongoing program of research on testing psychosocial treatments for substance use disorders that goes back to 1976 when a group at Penn began to work together on this topic. The research group includes: A. Thomas McLellan, George Woody, Charles O~Brien and myself. Our collaboration has resulted in nine contributions so far for substance abuse treatments that are related to this proposal. My major aim is to continue to work on completion of the NIDA Cocaine Collaborative Study, a major project in the portfolio of the NIDA. In study 1, data is being examined for predictive factors mainly by means of regression equations against outcome measures. In study 1 we have completed the randomization of subjects and are now treating the last patients entered into the study, following the patients who are still in treatment with monthly assessments and then doing the follow up after the treatment. Another aim is to continue my substudy (study 2) of the NIDA Collaborative Study which involves the development and testing of therapeutic alliance measures, because they are among the main predictive factors of outcome. Another aim is to do a comparative psychotherapy trial examining Supportive-Expressive Psychotherapy (SE) and individual Drug counseling (IDC) treatments, plus adjunctive behavioral reinforcement for HIV positive, cocaine dependent women. I am slated to be responsible for selection, training, and supervision of the SE therapists and acting as faculty mentor to the PE. This study has two primary aims: 1) to develop an effective treatment program for substance abusing women who are seropositive for the HIV virus. Lastly, I am starting to examine possible predictors of relapse within the content of the therapy sessions, first for SE therapy and then for Ct and IDC sessions. We will also examine the relationship of in-session predictors of relapse and therapeutic alliance. I~ve chosen to apply for only a three year renewal instead of the usual five, because the project that I am in, the NIDA cocaine Collaborative study, will be completed in 3 and I am working on completing it. My average work week will continue unchanged: at least 55 hours per week.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Scientist Award (K05)
Project #
5K05DA000168-30
Application #
2897572
Study Section
Human Development Research Subcommittee (NIDA)
Project Start
1992-07-17
Project End
2000-06-30
Budget Start
1999-07-01
Budget End
2000-06-30
Support Year
30
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Psychiatry
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Stulz, Niklaus; Thase, Michael E; Gallop, Robert et al. (2011) Psychosocial treatments for cocaine dependence: the role of depressive symptoms. Drug Alcohol Depend 114:41-8
Stulz, Niklaus; Gallop, Robert; Lutz, Wolfgang et al. (2010) Examining differential effects of psychosocial treatments for cocaine dependence: an application of latent trajectory analyses. Drug Alcohol Depend 106:164-72
Gallop, Robert J; Crits-Christoph, Paul; Ten Have, Thomas R et al. (2007) Differential transitions between cocaine use and abstinence for men and women. J Consult Clin Psychol 75:95-103
Weiss, Roger D; Griffin, Margaret L; Gallop, Robert J et al. (2005) The effect of 12-step self-help group attendance and participation on drug use outcomes among cocaine-dependent patients. Drug Alcohol Depend 77:177-84
Siqueland, Lynne; Crits-Christoph, Paul; Barber, Jacques P et al. (2004) What aspects of treatment matter to the patient in the treatment of cocaine dependence? J Subst Abuse Treat 27:169-78
Crits-Christoph, Paul; Gibbons, Mary Beth Connolly; Barber, Jacques P et al. (2003) Mediators of outcome of psychosocial treatments for cocaine dependence. J Consult Clin Psychol 71:918-25
Woody, George E; Gallop, Robert; Luborsky, Lester et al. (2003) HIV risk reduction in the National Institute on Drug Abuse Cocaine Collaborative Treatment Study. J Acquir Immune Defic Syndr 33:82-7
Siqueland, Lynne; Crits-Christoph, Paul; Gallop, Bob et al. (2002) Who starts treatment: engagement in the NIDA collaborative cocaine treatment study. Am J Addict 11:10-23
Siqueland, Lynne; Crits-Christoph, Paul; Gallop, Robert et al. (2002) Retention in psychosocial treatment of cocaine dependence: predictors and impact on outcome. Am J Addict 11:24-40
Crits-Christoph, P; Siqueland, L; McCalmont, E et al. (2001) Impact of psychosocial treatments on associated problems of cocaine-dependent patients. J Consult Clin Psychol 69:825-30

Showing the most recent 10 out of 17 publications